Related Experiment Videos
A pharmacokinetic study of cefoperazone
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|August 1, 1985
Summary
Cefoperazone exhibits a prolonged half-life in rat serum and kidneys. Notably, the antibiotic was absent in cellular mitochondria and lysosomes, indicating reduced potential for kidney damage.
Area of Science:
- Pharmacology
- Toxicology
- Drug Metabolism
Background:
- Cefoperazone is a third-generation cephalosporin antibiotic.
- Understanding its pharmacokinetic profile and tissue distribution is crucial for assessing potential toxicity.
- Intracellular drug accumulation in organelles like mitochondria and lysosomes can be linked to organ damage.
Purpose of the Study:
- To investigate the pharmacokinetic properties of cefoperazone in rats.
- To determine the tissue distribution of cefoperazone, specifically examining its presence in cellular organelles.
- To evaluate the potential nephrotoxic characteristics of cefoperazone based on its distribution pattern.
Main Methods:
- Pharmacokinetic analysis of cefoperazone in rat serum and kidney tissues.
- Subcellular fractionation to isolate mitochondria and lysosomes from experimental animal tissues.
- Quantification of cefoperazone concentrations in different tissue fractions using appropriate analytical techniques.
Main Results:
- Cefoperazone demonstrated a prolonged half-life in both serum and kidney tissues of rats.
- The antibiotic was consistently undetected in the mitochondrial and lysosomal fractions across all tested animals.
- This specific distribution pattern suggests limited intracellular accumulation in key organelles.
Conclusions:
- The pharmacokinetic profile of cefoperazone in rats is characterized by extended presence in serum and kidneys.
- The absence of cefoperazone in mitochondria and lysosomes indicates a low likelihood of direct cellular toxicity within these organelles.
- These findings suggest that cefoperazone possesses favorable, low nephrotoxic characteristics.